SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/BB7E31C8C0306C12721E404FBED84DF5B5327F71155A4B32D3C3B5D0D19573F9053AD2268B12CE321283E3D94F3F8D69>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/BB7E31C8C0306C12721E404FBED84DF5B5327F71155A4B32D3C3B5D0D19573F9053AD2268B12CE321283E3D94F3F8D69
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/BB7E31C8C0306C12721E404FBED84DF5B5327F71155A4B32D3C3B5D0D19573F9053AD2268B12CE321283E3D94F3F8D69
http://www.w3.org/2000/01/rdf-schema#comment
"These results demonstrate that scavenger class B type 1 receptor (SR-B1) is essential for infection with hepatitis C virus (HCV) produced in vitro and in vivo and suggest the possible use of anti-SR-B1 antibodies as therapeutic agents."
xsd:string
http://purl.uniprot.org/uniprot/#_F59BC05C3D65F7BDD39A305C0C33E738148CF21442678064D7A2DD97EB2B29CCEC6E09B36B0DE7D6175C6F35D3F17C3B
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/BB7E31C8C0306C12721E404FBED84DF5B5327F71155A4B32D3C3B5D0D19573F9053AD2268B12CE321283E3D94F3F8D69
http://purl.uniprot.org/uniprot/B4E3I1
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/BB7E31C8C0306C12721E404FBED84DF5B5327F71155A4B32D3C3B5D0D19573F9053AD2268B12CE321283E3D94F3F8D69
http://purl.uniprot.org/uniprot/#_B4E3I1-mappedCitation-17507483
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/BB7E31C8C0306C12721E404FBED84DF5B5327F71155A4B32D3C3B5D0D19573F9053AD2268B12CE321283E3D94F3F8D69